DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sookoian S, Pirola CJ.
Elafibranor for the treatment of NAFLD: one pill, two molecular targets and multiple effects in a complex phenotype.
Ann Hepatol 2016;
15 (04) 604-609
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.